Airway and lung tissue mechanics in asthma : Effects of albuterol

We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 1999, Vol.159 (1), p.169-178
Hauptverfasser: KACZKA, D. W, INGENITO, E. P, ISRAEL, E, LUTCHEN, K. R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 178
container_issue 1
container_start_page 169
container_title American journal of respiratory and critical care medicine
container_volume 159
creator KACZKA, D. W
INGENITO, E. P
ISRAEL, E
LUTCHEN, K. R
description We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p < 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (> 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.
doi_str_mv 10.1164/ajrccm.159.1.9709109
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69554121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69554121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-7320ab4944efcc69fdb9ad04687ef6a1c9deee35cc57fcf2b454d0d8b7a9a6413</originalsourceid><addsrcrecordid>eNpFkMtKxDAUhoMoo46-gUIW4q41aZOmcTcM4wUG3Ci4C6enidOhlzFpkXl7O0zR1fkP_2XxEXLDWcx5Jh5g6xGbmEsd81grpjnTJ-SCy1RGYvxPR81UGgmhP8_JZQhbxniSczYjM52rJE-zC7JYVP4H9hTaktZD-0X7KoTB0sbiBtoKA61aCqHfNEAf6co5i32gnaNQF0NvfVdfkTMHdbDX052Tj6fV-_IlWr89vy4X6wiTnPWRShMGhdBCWIeYaVcWGkomslxZlwFHXVprU4kolUOXFEKKkpV5oUBDJng6J_fH3Z3vvgcbetNUAW1dQ2u7IZhMSyl4cgiKYxB9F4K3zux81YDfG87MgZw5kjMjOcPNRG6s3U77Q9HY8q80oRr9u8mHgFA7Dy1W4X87EzpRLP0Fvnh4YA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69554121</pqid></control><display><type>article</type><title>Airway and lung tissue mechanics in asthma : Effects of albuterol</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>KACZKA, D. W ; INGENITO, E. P ; ISRAEL, E ; LUTCHEN, K. R</creator><creatorcontrib>KACZKA, D. W ; INGENITO, E. P ; ISRAEL, E ; LUTCHEN, K. R</creatorcontrib><description>We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p &lt; 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (&gt; 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.159.1.9709109</identifier><identifier>PMID: 9872836</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject>Administration, Inhalation ; Adolescent ; Adult ; Airway Resistance - drug effects ; Airway Resistance - physiology ; Albuterol - administration &amp; dosage ; Albuterol - therapeutic use ; Asthma - drug therapy ; Asthma - physiopathology ; Biological and medical sciences ; Bronchodilator Agents - administration &amp; dosage ; Bronchodilator Agents - therapeutic use ; Chronic obstructive pulmonary disease, asthma ; Female ; Forced Expiratory Volume - physiology ; Humans ; Lung Compliance - drug effects ; Lung Compliance - physiology ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Respiratory Mechanics - drug effects ; Spirometry</subject><ispartof>American journal of respiratory and critical care medicine, 1999, Vol.159 (1), p.169-178</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c280t-7320ab4944efcc69fdb9ad04687ef6a1c9deee35cc57fcf2b454d0d8b7a9a6413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,4011,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1649270$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9872836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KACZKA, D. W</creatorcontrib><creatorcontrib>INGENITO, E. P</creatorcontrib><creatorcontrib>ISRAEL, E</creatorcontrib><creatorcontrib>LUTCHEN, K. R</creatorcontrib><title>Airway and lung tissue mechanics in asthma : Effects of albuterol</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p &lt; 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (&gt; 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.</description><subject>Administration, Inhalation</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Airway Resistance - drug effects</subject><subject>Airway Resistance - physiology</subject><subject>Albuterol - administration &amp; dosage</subject><subject>Albuterol - therapeutic use</subject><subject>Asthma - drug therapy</subject><subject>Asthma - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Bronchodilator Agents - administration &amp; dosage</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Female</subject><subject>Forced Expiratory Volume - physiology</subject><subject>Humans</subject><subject>Lung Compliance - drug effects</subject><subject>Lung Compliance - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Respiratory Mechanics - drug effects</subject><subject>Spirometry</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtKxDAUhoMoo46-gUIW4q41aZOmcTcM4wUG3Ci4C6enidOhlzFpkXl7O0zR1fkP_2XxEXLDWcx5Jh5g6xGbmEsd81grpjnTJ-SCy1RGYvxPR81UGgmhP8_JZQhbxniSczYjM52rJE-zC7JYVP4H9hTaktZD-0X7KoTB0sbiBtoKA61aCqHfNEAf6co5i32gnaNQF0NvfVdfkTMHdbDX052Tj6fV-_IlWr89vy4X6wiTnPWRShMGhdBCWIeYaVcWGkomslxZlwFHXVprU4kolUOXFEKKkpV5oUBDJng6J_fH3Z3vvgcbetNUAW1dQ2u7IZhMSyl4cgiKYxB9F4K3zux81YDfG87MgZw5kjMjOcPNRG6s3U77Q9HY8q80oRr9u8mHgFA7Dy1W4X87EzpRLP0Fvnh4YA</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>KACZKA, D. W</creator><creator>INGENITO, E. P</creator><creator>ISRAEL, E</creator><creator>LUTCHEN, K. R</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>Airway and lung tissue mechanics in asthma : Effects of albuterol</title><author>KACZKA, D. W ; INGENITO, E. P ; ISRAEL, E ; LUTCHEN, K. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-7320ab4944efcc69fdb9ad04687ef6a1c9deee35cc57fcf2b454d0d8b7a9a6413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Inhalation</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Airway Resistance - drug effects</topic><topic>Airway Resistance - physiology</topic><topic>Albuterol - administration &amp; dosage</topic><topic>Albuterol - therapeutic use</topic><topic>Asthma - drug therapy</topic><topic>Asthma - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Bronchodilator Agents - administration &amp; dosage</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Female</topic><topic>Forced Expiratory Volume - physiology</topic><topic>Humans</topic><topic>Lung Compliance - drug effects</topic><topic>Lung Compliance - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Respiratory Mechanics - drug effects</topic><topic>Spirometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KACZKA, D. W</creatorcontrib><creatorcontrib>INGENITO, E. P</creatorcontrib><creatorcontrib>ISRAEL, E</creatorcontrib><creatorcontrib>LUTCHEN, K. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KACZKA, D. W</au><au>INGENITO, E. P</au><au>ISRAEL, E</au><au>LUTCHEN, K. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Airway and lung tissue mechanics in asthma : Effects of albuterol</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1999</date><risdate>1999</risdate><volume>159</volume><issue>1</issue><spage>169</spage><epage>178</epage><pages>169-178</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p &lt; 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (&gt; 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>9872836</pmid><doi>10.1164/ajrccm.159.1.9709109</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 1999, Vol.159 (1), p.169-178
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_miscellaneous_69554121
source MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Administration, Inhalation
Adolescent
Adult
Airway Resistance - drug effects
Airway Resistance - physiology
Albuterol - administration & dosage
Albuterol - therapeutic use
Asthma - drug therapy
Asthma - physiopathology
Biological and medical sciences
Bronchodilator Agents - administration & dosage
Bronchodilator Agents - therapeutic use
Chronic obstructive pulmonary disease, asthma
Female
Forced Expiratory Volume - physiology
Humans
Lung Compliance - drug effects
Lung Compliance - physiology
Male
Medical sciences
Middle Aged
Pneumology
Respiratory Mechanics - drug effects
Spirometry
title Airway and lung tissue mechanics in asthma : Effects of albuterol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A09%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Airway%20and%20lung%20tissue%20mechanics%20in%20asthma%20:%20Effects%20of%20albuterol&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=KACZKA,%20D.%20W&rft.date=1999&rft.volume=159&rft.issue=1&rft.spage=169&rft.epage=178&rft.pages=169-178&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.159.1.9709109&rft_dat=%3Cproquest_cross%3E69554121%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69554121&rft_id=info:pmid/9872836&rfr_iscdi=true